Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. John's wort NIH clinical efficacy trial in depression to begin this spring at Duke.

This article was originally published in The Tan Sheet

Executive Summary

ST. JOHN's WORT NIH DEPRESSION STUDY TO BEGIN IN SPRING, with the recruitment of approximately 336 subjects, the National Institutes of Health said Oct. 2. The study of the herb Hypericum perforatum for the treatment of major depressive disorder will be funded jointly by the National Institute of Mental Health, NIH's Office of Alternative Medicine and Office of Dietary Supplements. OAM allocated $1.5 mil. to the study from its FY 1997 budget for the year ended Sept. 30.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087621

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel